Remus Pharmaceuticals Ltd — Quarterly Results & Earnings

₹627.90

-9.48%

Profit Growth YoY24.91%Latest quarter

Sales Growth YoY46.77%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+24.91%

🔥 Exceptional growth

YoY Sales Growth+46.77%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

42.28

ROE

14.00%

ROCE

19.64%

💡

Growth Analysis

Remus Pharmaceuticals Ltd reported YoY profit growth of 24.91% and revenue growth of 46.77% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Remus Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.